Perez Samara, Tatar Ovidiu, Shapiro Gilla K, Dubé Eve, Ogilvie Gina, Guichon Juliet, Gilca Vladimir, Rosberger Zeev
Department of Psychology, McGill University, 1205 Dr. Penfield Avenue, Montreal, QC, H3A 1B1, Canada.
Lady Davis Institute for Medical Research, Jewish General Hospital, 4333 Cote Ste-Catherine Road Room 214, Montreal, QC, H3T 1E4, Canada.
BMC Public Health. 2016 Dec 5;16(1):1223. doi: 10.1186/s12889-016-3828-9.
HPV vaccination decision-making is a complex process that is influenced by multiple psychosocial determinants. Given the change in policy recommendation to include males in routine HPV vaccination, our goals were to assess the HPV vaccination uptake in Canada, to understand where Canadian parents were situated in the HPV vaccine decision-making process for their son, how they changed over time and which psychosocial determinants were relevant for this process.
We used an online survey methodology and collected data from a nationally representative sample of Canadian parents of boys aged 9-16 at baseline (T1, February 2014) and at 9 months' follow-up (T2). Our analyses were guided by the Precaution Adoption Process Model (PAPM), a theoretical health behavior model that classifies parents in one of six stages: unaware, unengaged, undecided, decided not to vaccinate, decided to vaccinate and those who had already vaccinated their sons. Rigorous methods were used to filter out careless responders: response variance, bogus items, psychometric antonyms and psychometric synonyms.
At T1 and T2, we received 3,784 and 1,608 respectively completed questionnaires; after data cleaning 3,117 (T1) and 1,427 (T2) were retained. Less than 3% of boys were vaccinated at both time points. At both T1 and T2, most parents (over 70%) belonged to the earlier vaccination adoption stages: 57% were unaware (T1) and 15.3% (T2); 20.9% were unengaged (T1) and 32.4% (T2); and 9.1% were undecided (T1) and 25.2% (T2). At follow-up, 37.7% of participants did not move from their initial PAPM decision-making stage. Most parents (55%) preferred to receive information from their healthcare provider (HCP) but only 6% (T1) and 12% (T2) had actually spoken with a HCP about the HPV vaccine for their son.
HPV vaccination uptake in Canadian boys was very low in the absence of a publicly funded HPV vaccination programs for boys. Optimal HPV information preferences were identified and can be used in interventions to increase HPV knowledge and increase HPV vaccine uptake. Intentions to vaccinate or planning to speak to one's HCP did not translate into action for most parents over the 9-month follow up; this finding is critical to consider to inform implementation strategies. Methodological challenges are described and suggestions for future research are offered.
人乳头瘤病毒(HPV)疫苗接种决策是一个复杂的过程,受到多种社会心理因素的影响。鉴于政策建议发生变化,将男性纳入常规HPV疫苗接种范围,我们的目标是评估加拿大HPV疫苗的接种情况,了解加拿大父母在为儿子进行HPV疫苗接种决策过程中所处的位置、他们如何随时间变化以及哪些社会心理因素与这一过程相关。
我们采用在线调查方法,从加拿大9至16岁男孩的父母这一具有全国代表性的样本中收集基线数据(T1,2014年2月)以及9个月随访数据(T2)。我们的分析以预防采纳过程模型(PAPM)为指导,这是一种理论性健康行为模型,将父母分为六个阶段之一: unaware,未参与,未决定,决定不接种,决定接种以及已经为儿子接种过疫苗的父母。我们使用严格的方法筛选粗心的受访者:反应方差、虚假项目、心理测量反义词和心理测量同义词。
在T1和T2阶段,我们分别收到3784份和1608份完整问卷;数据清理后,保留了3117份(T1)和1427份(T2)。在两个时间点,接种疫苗的男孩均不到3%。在T1和T2阶段,大多数父母(超过70%)处于疫苗接种采纳的早期阶段:57%处于 unaware阶段(T1),15.3%(T2);20.9%未参与(T1),32.4%(T2);9.1%未决定(T1),25.2%(T2)。在随访中,37.7%的参与者未从最初的PAPM决策阶段转变。大多数父母(55%)更愿意从医疗保健提供者(HCP)那里获取信息,但实际上只有6%(T1)和12%(T2)的父母就儿子的HPV疫苗问题与HCP进行过交谈。
在没有针对男孩的公共资助HPV疫苗接种计划的情况下,加拿大男孩的HPV疫苗接种率非常低。确定了最佳的HPV信息偏好,可用于干预措施,以增加HPV知识并提高HPV疫苗接种率。在9个月的随访中,对于大多数父母来说,接种疫苗的意愿或与HCP交谈的计划并未转化为实际行动;这一发现对于制定实施策略至关重要。描述了方法学上的挑战,并为未来研究提供了建议。